Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?

The strict answer to this question, including "all patients hospitalized with acute MI" is no based on the results of the recently reported EMPACT-MI trial. In this study of more than 6000 patients empagliflozin did not significantly improve a composite endpoint of hospitalization for heart failure ...